Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +39.43%
#3 Glidr Glidr +36.87%
#4 Humanity Humanity +27.14%
#5 Codatta Codatta +18.89%
#6 Walrus Walrus +18.20%
#7 Collector Crypt Collector Crypt +18.13%
#8 Provenance Blockchain Provenance Blockchain +17.25%
#9 Enso Enso +16.62%
#10 The Black Bull The Black Bull +14.46%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
株式のランク #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
株価
$0.117
最終同期: 2025-04-04
時価総額
$2.45M
変化（1日）
-13.59%
変化（1年）
0.00%
国
US
取引 Carmell Therapeutics Corporation (CTCX)

カテゴリー

Healthcare
Carmell Therapeutics Corporation（CTCX）のP/S比率
August 2026 時点のP/S比率 TTM: 3.52
Carmell Therapeutics Corporation の最新の財務報告および株価によると、現在のP/S比率（TTM）は 3.52 です。2023 年末時点でのP/S比率は 0.00 でした。
Carmell Therapeutics Corporation の P/S 比率の履歴（2021 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
2026 (TTM) 3.52 -99.90%
2024 3.48K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 188.58%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 187.49%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 34.60%
BE